Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intrapericardial cisplatin for malignant tamponade].

R Pavón Jiménez1, J C García Rubira, J T García Martínez

  • 1Unidad Coronaria. Servicios de Cardiología. Hospital Universitario Virgen Macarena. Sevilla. kaito@arrakis.es

Revista Espanola De Cardiologia
|April 12, 2000
PubMed
Summary

Intrapericardial cisplatin effectively treats malignant pericardial effusion and prevents recurrence. This safe and painless procedure offers a promising alternative for managing malignant pericardial tamponade.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.

Radiologia·2018
Same author

[Ventricular tachycardia in a young patient].

Revista clinica espanola·2007
Same author

[Enlargement of QT-interval in a patient with coronary disease treated with mianserin].

Anales de medicina interna (Madrid, Spain : 1984)·2003
Same author

[Thromboembolism prevention in acute myocardial infarction].

Revista clinica espanola·2001
Same author

[Spanish Society of Cardiology practice guidelines on arterial hypertension].

Revista espanola de cardiologia·2000
Same author

[Influence of coronary risk factors in secondary prevention: tobacco].

Revista espanola de cardiologia·1999

Area of Science:

  • Oncology
  • Cardiology
  • Pharmacology

Context:

  • Malignant pericardial effusion often leads to recurrent cardiac tamponade, necessitating frequent interventions.
  • Current management strategies for malignant pericardial effusion can be cumbersome and have limitations.
  • Pericardiocentesis, while relieving tamponade, has a high rate of fluid reaccumulation.

Purpose:

  • To evaluate the safety and efficacy of intrapericardial cisplatin administration for malignant pericardial tamponade.
  • To assess the recurrence rate of pericardial effusion following intrapericardial cisplatin treatment.
  • To determine the impact of intrapericardial cisplatin on patient survival.

Summary:

  • A study involving 6 patients with malignant pericardial effusion (causes included breast, lung, ovarian cancer, and fibrosarcoma) was conducted.

Related Experiment Videos

  • Intrapericardial cisplatin was administered, resulting in a painless procedure with no reported complications.
  • No recurrences of pericardial effusion were observed, with a mean survival of 5.6 months (range 2-18 months).

    • Impact:

    • Intrapericardial cisplatin demonstrates safety and effectiveness in managing malignant pericardial tamponade.
    • This approach offers a viable method to prevent the reaccumulation of pericardial fluid.
    • The findings suggest a potential improvement in patient outcomes for malignant pericardial effusion.